Skip to content
ppharmaranks
Menu
Class IIOngoing

PRASUGREL TABLETS recall

FDA recall D-0287-2025 · initiated Mar 5, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 26, 2025How we research

Golden State Medical Supply Inc. recalled PRASUGREL TABLETS in Mar 2025 — an FDA Class II recall (D-0287-2025) because Failed Dissolution Specifications.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Dissolution Specifications

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot no's: GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405, Exp.: 04/30/2026

Quantity recalled: 2,601 30-count bottles

Details

Product
PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30
Recalling company
Golden State Medical Supply Inc.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Mar 5, 2025
FDA report date
Mar 26, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was PRASUGREL TABLETS recalled?
Golden State Medical Supply Inc. recalled PRASUGREL TABLETS in Mar 2025 — an FDA Class II recall (D-0287-2025) because Failed Dissolution Specifications. May cause temporary or medically reversible harm; low probability of serious harm.
Why was PRASUGREL TABLETS recalled?
Per the FDA enforcement record, the reason for recall D-0287-2025 was: Failed Dissolution Specifications
Is a recalled PRASUGREL TABLETS dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of PRASUGREL TABLETS are affected?
Distributed: U.S. Nationwide. The recall covers these lots — Lot no's: GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405, Exp.: 04/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0287-2025.

Source: openFDA Drug Enforcement record D-0287-2025

← All drug recalls